Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2025-12-24 @ 5:39 PM
NCT ID:
NCT01080768
Eligibility Criteria:
Inclusion Criteria:
* Patients (male or female) with hypertension aged between 18-75 yrs.
* Patients not treated with amlodipine or no amlodipine in previous 1 year.
* Post-menopausal females
Exclusion Criteria:
* Patients unable to switch from prior hypertensive medication.
* Severe hypertension.
* Pregnant or nursing females.
* Patients with Type 1 or Type 2 diabetes mellitus
* History of immunodeficiency diseases, including a positive Human immunodeficiency virus (HIV) (Enzyme-linked immunosorbent assay \[ELISA\] and Western blot) test result.
* A positive Hepatitis B surface antigen (HBsAg) or Hepatitis C test result.
Other protocol-defined inclusion/exclusion criteria are applied
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01080768
Study Brief:
Protocol Section:
NCT01080768